ACCELLTA
Accellta offers a range of revolutionary solutions for better affordability and quality of stem cell culturing. Accellta's technologies are the result of over 15 years of pioneering research and development at the Stem Cell Center in the Technion’s Rappaport Faculty of Medicine.
ACCELLTA
Social Links:
Industry:
Biotechnology Medical
Founded:
2012-01-01
Address:
Haifa, Hefa, Israel
Country:
Israel
Website Url:
http://www.accellta.com
Total Employee:
11+
Status:
Active
Contact:
+97248291070
Email Addresses:
[email protected]
Total Funding:
50 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome
Similar Organizations
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Accellta
Newest Events participated
Official Site Inspections
http://www.accellta.com Semrush global rank: 8.74 M Semrush visits lastest month: 261
- Host name: euro68.jetserver.net
- IP address: 185.53.210.155
- Location: Doetinchem Netherlands
- Latitude: 51.9631
- Longitude: 6.3065
- Timezone: Europe/Amsterdam
- Postal: 7003
More informations about "Accellta"
Home - Accellta
Accellta offers innovative and cost-effective solutions for cell cultivation, bioprocessing, medium optimization, and CDMO services across multiple industries. With decades of research …See details»
Welcome to Accellta - Accellta Ltd.
Accellta provides custom-made solutions for mass production of high quality human embryonic and induced pluripotent stem cells, progenitors and differentiated cells for drug discovery, …See details»
About Us - Accellta
At Accellta, we’re revolutionizing the future of biotechnology. Since 2012, under the leadership of globally recognized stem cell expert Dr. Michal Amit, we’ve been at the forefront of …See details»
Accellta - Crunchbase Company Profile & Funding
Accellta offers a range of revolutionary solutions for better affordability and quality of stem cell culturing. Accellta's technologies are the result of over 15 years of pioneering research and …See details»
Accellta Company Profile | Management and Employees List
Accellta specializes in innovative, high quality and cost-effective media and custom-made technologies for culturing and differ entiation of human stem cells in unique 3D suspension …See details»
Accellta 2025 Company Profile: Valuation, Funding & Investors
Accellta General Information Description. Developer of stem cell culture technologies designed to offer affordability and quality of stem cell culturing for custom-made process development and …See details»
Accellta - Israeli Startup | Startup Nation Finder
May 25, 2016 Accellta's manufacturing facility adheres to Good Manufacturing Practice (GMP) guidelines, supporting industrial-scale cell banking and clinical batch production. The …See details»
Accellta - Funding, Financials, Valuation & Investors - Crunchbase
Accellta offers a range of revolutionary solutions for better affordability and quality of stem cell culturing. New. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
Accellta - VentureRadar
Accellta's technologies are the result of over 15 years of pioneering research and development at the Stem Cell Center in the Technion’s Rappaport Faculty of Medicine. Our products include …See details»
Accellta - Crunchbase
Accellta offers a range of revolutionary solutions for better affordability and quality of stem cell culturing.See details»
Accellta Company Profile - Office Locations, Competitors ... - Craft
Accellta is a company that develops stem cell manufacturing technologies. It provides custom-made solutions for the production of human embryonic and induced pluripotent stem cells, …See details»
Accellta Market Study | Accellta | Project | Fact sheet | H2020 ...
Aug 8, 2022 Accellta's future vision is to become a leading provider of premium quality differentiated cell lines and services to customers, which include pharmaceutical and …See details»
Accellta - Company Profile - Tracxn
Feb 8, 2025 Accellta is focussed on providing custom-made solutions for the mass production of human embryonic and induced pluripotent stem cells, progenitors and differentiated cells for …See details»
Accellta - Products, Competitors, Financials, Employees, …
About Accellta. Accellta is a biotechnology company specializing in stem cell manufacturing solutions. The company offers custom-made solutions for mass production of high-quality …See details»
Accellta - Protein Directory
Accellta develops, manufactures and markets a range of game-changing solutions for the cost-effective industrialization of stem cell manufacturing. Our technologies can save more than …See details»
Our Technology - Accellta
Backed by over two decades of expertise in stem cell biology, Accellta has revolutionized cell culture technology. We are the first in the world to develop and refine a platform enabling large …See details»
Accellta | Forward Fooding - Powering the Food & Food Tech …
About Accellta. Next Generation Food & Drinks. Cellular agriculture . accellta.com. Series A * Haifa, Israel. Our company has female founder(s) *Latest funding round undertaken by the …See details»
Accellta - Contacts, Employees, Board Members, Advisors & Alumni
Accellta offers a range of revolutionary solutions for better affordability and quality of stem cell culturing. New. ... Experience the new Crunchbase, powered by AI . Organization. Accellta . …See details»
Accellta – The Healthcare Stage
Accellta was founded 12 years ago with a mission to revolutionize the cultivation and manufacturing of stem cells. Stem cells are cells that can differentiate into various specialized …See details»
News Archive - Accellta
Sep 15, 2023 Accellta and Nano Dimension Joined Forces to Successfully BioPrint Stem Cell-Derived Tissues. Bio Tech. Read More. 19.04.16. Accellta Signs Collaboration Agreement with …See details»